NASDAQ:CTOR | Free Cash Flow | CITIUS ONCOLOGY, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$7.35M
2024-03-31-$191,690.00
2023-12-31-$218,777.00
2023-03-31-$168,799.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$5.49M
2024-09-30$126,353.00
2023-12-31-$601,304.00
2022-12-31-$47,968.00